1508TiPDurvalumab in frail and elder patients with stage four NSCLC: The DURATION trial. (23rd October 2018) - Kuon, J; Bozorgmehr, F; Schneider, M A; Krisam, J; Lasitschka, F; Serke, M; Schuette, W; Moosmann, N; Gleiber, W; Faehling, M; Wermke, M; Schuett, P; et al.